Abstract
In this issue of The Lancet Infectious Diseases, Evelina Tacconelli and colleagues, and the WHO Pathogens Priority List Working Group, 1 Tacconelli E Carrara E Savoldi A et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria. Lancet Infect Dis. 2017; (published online Dec 21.)http://dx.doi.org/10.1016/S1473-3099(17)30753-3 Summary Full Text Full Text PDF Scopus (2321) Google Scholar describe how WHO created a priority list of antibiotic-resistant bacteria to support research into and development of effective drugs. The authors used a multicriteria decision analysis method to prioritise antibiotic-resistant bacteria: 20 bacterial species with 25 patterns of acquired resistance and ten criteria to assess priority were used to generate the list. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisFuture development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria. The global strategy should include antibiotic-resistant bacteria responsible for community-acquired infections such as Salmonella spp, Campylobacter spp, N gonorrhoeae, and H pylori. Full-Text PDF
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
